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ABSTRACT
Moonlighting or multitasking proteins refer to those proteins with two or more functions performed by a single polypeptide
chain. Proteins that belong to key ancestral functions and metabolic pathways such as primary metabolism typically
exhibit moonlighting phenomenon. We have collected 698 moonlighting proteins in MultitaskProtDB-II database. A survey
shows that 25% of the proteins of the database correspond to moonlighting functions related to pathogens virulence
activity. Why is the canonical function of these virulence proteins mainly from ancestral key biological functions (especially
of primary metabolism)? Our hypothesis is that these proteins present a high conservation between the pathogen protein
and the host counterparts. Therefore, the host immune system will not elicit protective antibodies against pathogen
proteins. The fact of sharing epitopes with host proteins (known as epitope mimicry) might be the cause of autoimmune
diseases. Although many pathogen proteins can be antigenic, only a few of them would elicit a protective immune
response. This would also explain the lack of successful vaccines based in these conserved moonlighting proteins.
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INTRODUCTION
Moonlighting and multitasking proteins refer to those proteins
with two or more functions performed by a single polypep-
tide chain. Moonlighting proteins present alternative functions
(named canonical and moonlighting) that are mostly affected
by cellular localization, cell type, oligomeric state, concentra-
tion of cellular ligands, substrates, cofactors, products or post-
translational modifications (Huberts 2010; Copley 2012; Jeffery
2014). Usuallymultitasking proteins are experimentally revealed
by serendipity. The appearance of a new function within a
polypeptide can become an advantage for the microorganism
because it permits a lower number of genes and proteins, thus,
making its genome more compact. In any case, these pro-
teins complicate the interpretation of knock-outs, DNA arrays,
metabolomics, systems biology, drug pharmacokinetics, phar-
macodynamics and toxicity assays/analyses. It is remarkable
that moonlighting is typically exhibited by proteins that are
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Figure 1. Clustal Omega multialignment of human and pathogen enolases. Highlighted in yellow shows the predicted B-cell epitopes in all the enolase protein se-
quences. Asterisks depict fully conserved amino acids.Most humanpredicted epitopesmatch to highly conserved amino acids stretches.Microorganisms are as follows:
AERHY = Aeromonas hydrophila; NEIMB = Neisseria meningitidis; BORBU = Borrelia burgdorferi; BACAN = Bacillus anthracis; STAAU = Staphylococcus aureus; STRPN = Strep-
tococcus pneumoniae; STRPY = Streptococcus pyogenes; STRMU = Streptococcus mutans; STRSU = Streptococcus suis.
ubiquitous and belong to an ‘ancestral’ function or pathway, for
example primary metabolism.
Currently, two updated multitasking/moonlighting protein
databases exist: MultitaskProtDB-II (Franco et al. 2018) and
MoonProt (Chen et al. 2018). MultitaskProtDB-II contains 694
multitasking proteins. A remarkable fact is that 25% of these
known multitasking proteins present a moonlighting function
related to the pathogen’s virulence activity (Table S1, Sup-
porting Information). Moreover, their canonical function is to
be an enzyme of key pathways like glycolysis or Krebs cycle
(Henderson and Martin 2011; Amblee and Jeffery 2015). It is
remarkable that these proteins are intracellular and, without
having a canonical signal peptide or secretion motifs, they go
outside the microorganism cell membrane by a still unknown
mechanism. These facts rise two major questions:
Why is the canonical function of these virulence proteins
mainly from ancestral key biological functions (especially of pri-
marymetabolism)? And, why are they shared bymany pathogen
species?
The high percentage of moonlighting proteins of our
database that have been reported as pathogen virulence factors
prompts a question: Are most of them true virulence factors?
Since the function of pathogen moonlighting proteins is related
to key metabolism, hence essential proteins, it is difficult to
generate mutants or full-gene knock-outs in order to per-
form direct experimental demonstrations on their virulence
involvement. However, some newly designed and naturally
existing mutants do not lose the essential canonical function
but become non-virulent in in vivo challenges. For example,
in anaerobic conditions bacteria lack an operative glycolytic
pathway. Neisseria meningitidis, which uses fructose-1,6 biphos-
phate aldolase as an adhesin, loses the adherence capacity to
the epithelial and endothelial cells when isogenically mutated,
but this capacity returns in the complementation assay (Tunio
et al. 2010). Another example of modification of a glycolytic
enzyme without losing its canonical function is glyceralde-
hyde phosphate dehydrogenase of Streptococcus pyogenes. Here,
a small hydrophobic amino acid sequence has been added
reducing the amounts of GAPDH at the surface of the microor-
ganism and this mutant loses its virulence in mice (Jin, Agarwal
and Pancholi 2011). Finally, another example of a bacterial
moonlighting protein acting as a toxin is GroEL, the archetypal
category of virulence factors. This protein is an insect neuro-
toxin in Enterobacter aerogens, but is inactive in Escherichia coli
when mutated in three amino acids (Yoshida et al.2001).
We propose a hypothesis based on our previouswork (Amela,
Cedano and Querol 2007). In that work, we suggested that,
given that one of the most important tasks of the immune sys-
tem is the differentiation between self and non-selfantigens,
this systemwould discard eliciting protective antibodies against
pathogen proteins sharing epitopes with host proteins (epitope
mimicry), because this could be the cause of autoimmune dis-
eases (Benoist and Mathis 2001). It means that although many
pathogen proteins can be antigenic only a few of them would
elicit a protective immune response.
RESULTS AND DISCUSSION
As said before, most of the moonlighting proteins belong to the
central metabolism (glycolysis, Krebs cycle. . . ) and their enzyme
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amino acid sequences are highly conserved throughout evo-
lution (Henderson and Martin 2011; Amblee and Jeffery 2015).
Therefore, they probably share epitopes. Obviously, this has a
particular importance for the design and development of suc-
cessful subunit recombinant vaccines, especially with the ad-
vent of reverse vaccinology.
Figure 1 shows a multialignment of nine representatives of
one of themost prevalent virulencemoonlighting proteins, eno-
lases, versus the human orthologous protein, alpha-enolase.
The predicted B-cell epitopes are highlighted in yellow in all
the enolase protein sequences. As can be seen, many human
epitopes overlap with highly conserved amino acid sequence
stretches present in all enolases. According to our hypothesis
the human immune system would not elicit protective anti-
bodies against the pathogen’s enolases. As we have previously
described, there are examples in which even a lower number
of shared epitopes can be responsible of an autoimmune re-
sponse (Amela, Cedano and Querol 2007). Table S2 (Support-
ing Information) shows other examples of other pathogen’s
moonlighting enzymes (GAPDH, PDK, PMD. . . ) aligned with the
human orthologous counterpart. As can be seen, they also
match stretches of amino acid sequence and overlap predicted
epitopes.
In fact, it has been reported that streptococcal enolase cross-
react with human enolase and may be involved in autoimmune
conditions and complications following infection (Fontan et al.
2000; Cole et al. 2005).
An exhaustive inspection of Violinet database shows that no
moonlighting protein is, as a vaccine, in the market, which is
a good indicator of being a true protective antigen. Few (some
chaperones such as GroEL and hsp70) are even in the lower Vi-
olinet status (research) —some chaperones such as GroEL and
hsp70. Moreover, in all the cases involving moonlighting pro-
teins, the assays have been done on mice, guinea pig or rab-
bit showing quite a low level of protection (≤20%) or the au-
thors merely indicate the presence of ‘some degree’ of immune
response. According to Violinet, the recombinant proteins that
have reached the market (or are close to doing it, like an ebola
vaccine) are shown in Table 1.
A BLASTP pair alignment of these proteins versus the human
and mammal proteomes shows that the output states No signif-
icant similarity found.
These results agree with our hypothesis that the host, in or-
der to avoid an autoimmune response, avoids eliciting protec-
tive antibodies against pathogen proteins with which it shares
epitopes. Therefore, pathogen evolution would positively select
those virulence proteins whose amino acid sequence is con-
served to some degree. Our hypothesis would explain the lack
of successful subunit vaccines present in the market that are
based on these moonlighting proteins. On the other hand, due
Table 1. Current recombinant protein vaccines.
Pathogen Host Recombinant protiens
Neisseria meningitidis Human NHBA, NadA and FHbp
Borrelia burgdorferi Human OspA
Bordetella pertussis Human fhaB
Human papilloma virus Human L1
Hepatitis B virus Human Capsid protein
Zaire ebola virus Human Vp35
Pig circovirus Pig Capsid protein
Pasteurella multocida serotype D Pig Dermonecrotoxin
to the degree of conserved sequence and shared and epitopes,
it should exist cross-strain protective immunity using these
moonlighting proteins as subunit vaccines, which is not the
case. For all these reasons, a strategy based on designing a vac-
cine using a moonlighting protein as the main antigen might be
unsuccessful.
MATERIALS AND METHODS
Pathogen virulence proteins that are moonlighting were col-
lected fromMultitaskProtDB-II (Franco et al. 2018), (see Table S1,
Supporting Information). The vaccine candidate proteins were
obtained from the database Violinet (He et al. 2014), which
contains 800 proteins that have been tested as subunit vaccines
(recombinant or isolated) and then purified. These proteins
can be real marketed vaccines, licensed as successful ones, or
having only a ‘research’ status.
Continuous B-cell epitopes of the human orthologous pro-
teins of the previously said pathogen virulence proteins (i.e.
enolases) were predicted using the algorithm BepiPred (Larsen,
Lund and Nielssen 2006). Protein sequence alignments were
performed with BLASTP of the NCBI server (Altschul et al. 1997),
and multialignments were done with Clustal–Omega of the EBI
Server (Li et al. 2015). Both analyses were performed under the
server default parameters.
SUPPLEMENTARY DATA
Supplementary data are available at FEMSPD online.
FUNDING
This research was supported by Ministerio de Economı´a y Com-
petitividad of Spain [ BFU2013-50176-EXP, BIO2013-48704-R and
BIO2017-84166R], by the Centre de Refere`ncia de R+D de Biotec-
nologia de la Generalitat de Catalunya, and from the Comisio´n
Coordinadora del Interior de Uruguay.
Conflict of interest. None declare.
REFERENCES
Altschul SF, Madden TL, Scha¨ffer AA et al. Gapped BLAST and
PSI-BLAST: a new generation of protein database search pro-
grams. Nucleic Acids Res 1997;25:3389–402.
Amblee V, Jeffery C. Physical features of intracellular pro-
teins that moonlight on the cell surface. PLoS One.
2015;10:e0130575. doi: 10.1371 /journal.pone.0130575.
Amela I, Cedano J, Querol E. Pathogen proteins eliciting antibod-
ies do not share epitopeswith host proteins: a bioinformatics
approach. PLoS One 2007;2:e512.
Benoist C, Mathis D. Autoimmunity provoked by infection: how
good is the case for T cell epitope mimicry? Nat Immunol
2001;2:797–801.
Chen C, Zabad S, Liu H et al. MoonProt 2.0: an expansion and
update of the moonlighting proteins database. Nucleic Acids
Res 2018;46:D640–4.
Cole JN, Ramirez RD, Currie BJ et al. Surface analyses and im-
mune reactivities of major cell wall-associated proteins of
group A Streptococcus. Infect Immun 2005;73:3137–46.
Copley SD. Moonlighting is mainstream: paradigm adjustment
required. Bioessays 2012;34:578–88.
Fontan PA, Pancholi V, Nociari MM et al. Antibodies to strep-
tococcal surface enolase react with human alpha-enolase:
4 Pathogens and Disease, 2018, Vol. 76, No. 5
implications in poststreptococcal sequelae. J Infect Dis
2000;182:1712–21.
Franco-Serrano L, Herna´ndez S, Calvo A et al.MultitaskProtDB-II:
an update of a database of multitasking/moonlighting pro-
teins/moonlighting proteins. Nucleic Acids Res 2018;46:D645–
8.
Henderson B, Martin A. Bacterial virulence in the moon-
light: multitasking bacterial moonlighting proteins are vir-
ulence determinants in infectious disease. Infect Immun
2011;79:3476–91.
He Y, Racz R, Sayers S et al. Updates on the web-based VIO-
LIN vaccine database and analysis system. Nucl Acids Res
2014;42:D1124–32.
Huberts DH, van der Klei IJ. Moonlighting proteins: an intriguing
mode of multitasking. Biochim Biophys Acta 2010;1803:520–
5.
Jeffery CJ. An introduction to protein moonlighting. Biochem Soc
Trans. 2014;42:1679–83.
Jin H, Agarwal S, Pancholi V. Surface export of GAPDH/SDH, a
glycolytic enzyme, is essential for Streptococcus pyogenes vir-
ulence. mBio. 2011;2:e00068–11.
Larsen JEP, Lund O, Nielssen M. Improved method for predicting
linear B-cell epitopes. Immunome Res 2006;2:2.
Li W, Cowley A, Uludag M et al. The EMBL-EBI bioinformatics
web and programmatic tools framework. Nucleic Acids Res
2015;43:W580–4.
Tunio SA, Oldfield NJ, Berry A et al. The moonlighting pro-
tein fructose-1,6 biphosphate aldolase of Neisseria menin-
gitidis adherence to human cells. BMC Microbiol. 2010;76:
605–15.
Yoshida N, Okeda K, Watanabe E et al. Protein function. Chaper-
onin turned insect toxin. Nature. 2001;411:44.
